TAKEDA PHARMA (TKPYY) earnings
Quarterly and annual TKPYY reports and results, each read against the price at its own news timestamp. Back to the TKPYY overview →
No TKPYY earnings events in the measured window.
Nothing matched in the current window — the TKPYY overview has every event we measure for this name.
Get an email when TKPYY moves on news →Keep exploring
More TKPYY: analyst actions → · SEC filings → · TKPYY overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | 192 | -1.42% | 30% |
| Kezar Life Sciences, Inc. (KZR) | 192 | +0.14% | 55% |
| Arbutus Biopharma Corporation (ABUS) | 191 | +0.11% | 52% |
| BeiGene, Ltd. - American Depositary Shares (BGNE) | 191 | +0.11% | 52% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.